Cyp2d6 Substrates Highly Dependent On Cyp2d6 For Clearance has 1 known drug interaction based on U.S. FDA drug labeling data. Of these, 1 are contraindicated combinations that should be avoided entirely. Notable interactions include combinations with Mavorixafor. Patients taking Cyp2d6 Substrates Highly Dependent On Cyp2d6 For Clearance should inform their healthcare provider of all current medications — including over-the-counter drugs and supplements — to avoid potentially harmful combinations. Data sourced from OpenFDA and the NIH National Library of Medicine.
- Total
- 1
- Contraindicated
- 1
Contraindicated (1)
- Cyp2d6 Substrates Highly Dependent On Cyp2d6 For Clearance + Mavorixafor— Concomitant use is contraindicated. Mavorixafor inhibits CYP2D6, increasing substrate exposure and risk of adverse react…